Patents Assigned to Universite de Geneve
  • Publication number: 20190262788
    Abstract: Magnetic stir bar (1) for use with a magnetic stirrer, said magnetic stir bar (1) comprising at least one permanent magnet (2) for spinning said magnetic stir bar (1) when said magnetic stir bar (1) is subjected to a rotating magnetic field; and a chamber (3) for storing a product inside said magnetic stir bar (1), wherein said magnetic stir bar (1) has a closed configuration in which said chamber (3) is closed, said magnetic stir bar (1) being maintained in said closed configuration under the effect of a first force (f), and an open configuration in which said chamber (3) is open, said magnetic stir bar (1) being maintained in said open configuration under the effect of a second force (F); and wherein said magnetic stir bar (1) is adapted to automatically reconfigure itself from said closed configuration to said open configuration when said magnetic stir bar (1) is spun at or above a threshold rotational speed (?t).
    Type: Application
    Filed: June 16, 2017
    Publication date: August 29, 2019
    Applicant: Université de Genève
    Inventors: Stéphane Rosset, Clément Mazet, Christophe Girard
  • Publication number: 20190243611
    Abstract: The invention is directed to a Quantum Random Number Generator comprising an emitting device (110) triggered by a signal representing an input bit x and adapted to generate and send a physical system (130) characterized by one of two possible quantum states determined by said input bit x, a measurement device (120) adapted to detect said physical system, to identify the quantum state of said physical system through an unambiguous state discrimination measurement and to generate an output b first representing whether the quantum state has been identified or not and, if it has been identified, which quantum state among the two possible quantum states was detected by the unambiguous state discrimination measurement to a processing device (140), the processing device (140) being adapted to estimate the entropy of the output b given the probabilities p(b|x) representing the probability of observing output b for a state preparation x, and a randomness extraction device (150) adapted to extract final random bit stre
    Type: Application
    Filed: October 6, 2017
    Publication date: August 8, 2019
    Applicant: Université de Genève
    Inventors: Anthony Christophe Mickaël MARTIN, Nicolas BRUNNER, Hugo Zbinden, Jonatan BRASK, Joseph BOWLES
  • Patent number: 10331412
    Abstract: A device for random number generation based on an optical process of quantum nature, including a light source emitting photons randomly, a light detector adapted to absorb the randomly emitted photons and to measure a number n of photons produced by the light source in a time interval T, and a randomness extractor. The detector includes a photon sensor acting as a photon-to-electron converter, an amplifier for converting the electron signal received from the photon sensor into a voltage and amplifying the voltage signal, as well as an analog-to-digital converter for processing the amplified signal received from the amplifier by encoding the amplified signal into digital values and sending these digital values to the randomness extractor for further processing such as to produce quantum random numbers (QRNs) based on the number of photons produced by the light source in a time interval T.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: June 25, 2019
    Assignee: Université de Genève
    Inventors: Bruno Sanguinetti, Anthony Martin, Nicolas Gisin, Hugo Zbinden
  • Publication number: 20190160085
    Abstract: The present invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome; wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di-saccharide, —O—C(O)—R4 and halogen, such as Cl, F or Br, wherein R4 is selected from H, alkyl, such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.
    Type: Application
    Filed: June 28, 2016
    Publication date: May 30, 2019
    Applicants: UNIVERSIDADE ESTADUAL PAULISTA JULIO DE MESQUITA FILHO, UNIVERSITE DE GENEVE
    Inventors: LUIZ LEONARDO SALDANHA, ANNE LIGIA DOKKEDAL BOSQUEIRO, JOSE ROBERTO BOSQUEIRO, NATHALIA APARECIDA DE PAULA CAMAFORTE HENRIQUES, PRISCILLA MARIA PONCE VAREDA, WAGNER VILEGAS, EMERSON FERREIRA QUEIROZ, LAURENCE MARCOURT, JEAN-LUC WOLFENDER
  • Patent number: 10258690
    Abstract: The present invention is directed to new 5-ALA derivatives, particles and formulation thereof, related methods of preparation and methods of use thereof. In particular, the invention relates to compounds of the invention, particles and formulation thereof useful in the treatment of a cancer and/or the diagnosis of a cancer cell such as in photodynamic therapy or photodynamic diagnosis.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: April 16, 2019
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Andrej Babic, Norbert Lange
  • Patent number: 10187205
    Abstract: System and methods for synchronizing and aligning quantum channel for Quantum Key Distribution. The primary object of the invention is to allow a Quantum Key Distribution (QKD) apparatus to work continuously with only two communication channels, a quantum communication channel and a service channel. This is achieved by linking the clock frequencies of both channels and completed by an over-sampling method for phase synchronization tracking. Clock signal carry is done through data using a clock data recovery encoding techniques. Having a continuous operating QKD system is not possible without a tracking system that enables phase alignment. This synchronization and alignment system and method for QKD has multiple benefits as it allows real-time synchronization with continuous data flow and is not dedicated to a specific quantum protocol.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: January 22, 2019
    Assignee: Université de Genève
    Inventors: Olivier Guinnard, Raphael Houlman
  • Patent number: 10087234
    Abstract: The invention relates to mimetic peptides of epitope(s) of Apolipoprotein A-I, diagnostic immunoassays comprising such mimetic peptides, as well as methods for diagnosing and methods for preventing and/or treating a cardiovascular disease.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: October 2, 2018
    Assignees: LES HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVE, HOFFMAN-LA ROCHE INC.
    Inventors: Nicolas Vuilleumier, Sabrina Pagano, Oliver Hartley, Hubert Gaertner, Priscila Camillo Teixeira, Paul Cutler, Philippe Ferber
  • Patent number: 10063891
    Abstract: A data compression method wherein said data comprises noise and information, comprising a data acquisition step, a pre-compression parameter selection step, wherein said pre-compression parameters are linked to an information loss, a compression step, and a storage step, the compression step being characterized in that it comprises a lossy pre-compression for removing some noise of the data, carried out using the pre-compression parameters selected in the selection step followed by lossless compression for compressing the remaining data.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: August 28, 2018
    Assignee: Université de Genève
    Inventors: Anthony Martin, Hugo Zbinden, Bruno Sanguinetti
  • Patent number: 10019646
    Abstract: A method for recognition and/or verification of authenticity of digital, and/or physical objects, comprising the steps of codebook training, object enrollment, and object verification, the latter consisting in object recognition and/or object authentication. The method uses two types of features, of codebooks, and of databases, which are specifically designed for identification, respectively authentication, the identification database and authentication database having different organizations. The invention is also directed to corresponding computer program means adapted to implement the proposed method, devices adapted for implementation of a method, as well as to applications which are particularly adapted for use of the proposed method.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: July 10, 2018
    Assignee: Université de Genève
    Inventors: Svyatoslav Voloshynovskiy, Maurits Diephuis
  • Patent number: 9809801
    Abstract: Provided herein are genetically modified arenaviruses suitable as vaccines against mycobacterial infections. The invention also relates to pharmaceutical compositions and methods for the prevention and treatment of mycobacterial infections. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of preventing and treating infections in Mycobacterium tuberculosis.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 7, 2017
    Assignee: Université de Genève
    Inventors: Elodie Anne Françoise Belnoue, Stéphanie Gabrielle Darbre Abdelrahman, Arun Thomas Kamath, Paul Lambert, Claire-Anne Siegrist-Julliard, Daniel David Pinschewer
  • Patent number: 9794067
    Abstract: A method of providing robust and secure fingerprints including, at an enrollment stage, the steps of providing a content x for which a fingerprint is to be provided, assigning an ID number to the content x, providing a secret key k, generating a fingerprint bx based on content x and secret key k, storing the generated fingerprint bx together with the assigned ID in a database, as well as, at an identification stage, the steps of extracting, for a given query content y which might result either from the enrolled content x or an unrelated content x?, an estimate fingerprint by based on content y, and secret key k, producing an estimated I{hacek over (D)} number based on the estimate fingerprint by for identifying the content x using said ID number stored in the database, or else rejecting the query.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: October 17, 2017
    Assignee: Université de Genève
    Inventor: Svyatoslav Voloshynovskiy
  • Patent number: 9757037
    Abstract: Apparatus for real-time in vivo bioluminescence monitoring in a conscious small animal, comprising a light-tight enclosure (4) with a base (16), side wall (19) and cover (20) configured for housing the small animal such that it may move freely, a bioluminescence detector system (6) comprising a light detector (22) for detecting the light emitted by said small animal connected to a data processing system, and a life-sustaining system (8) configured for maintaining the small animal alive for a prolonged period of time spanning from a few days to a few weeks.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: September 12, 2017
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Ueli Schibler, Andre Liani, Camille Saini, Luigi Bonacina, Jean-Pierre Wolf
  • Patent number: 9747077
    Abstract: A device for random number generation based on an optical process of quantum nature, including a light source emitting photons randomly, a light detector adapted to absorb the randomly emitted photons and to measure a number n of photons produced by the light source in a time interval T, and a randomness extractor. The detector includes a photon sensor acting as a photon-to-electron converter, an amplifier for converting the electron signal received from the photon sensor into a voltage and amplifying the voltage signal, as well as an analog-to-digital converter for processing the amplified signal received from the amplifier by encoding the amplified signal into digital values and sending these digital values to the randomness extractor for further processing such as to produce quantum random numbers (QRNs) based on the number of photons produced by the light source in a time interval T.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: August 29, 2017
    Assignee: Université de Genève
    Inventors: Bruno Sanguinetti, Anthony Martin, Nicolas Gisin, Hugo Zbinden
  • Patent number: 9730795
    Abstract: Endosseous implant to be applied to a human or animal bone, wherein the surface of the implant is made from titanium or a titanium alloy, said implant having a smooth or rough surface texture, which is characterized in that said surface has been treated with at least one selected organic phosphonate compound or a pharmaceutically acceptable salt or ester or an amide thereof; process for producing said implants.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: August 15, 2017
    Assignees: UNIVERSITE DE GENEVE, ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
    Inventors: Pierre Descouts, Björn-Owe Aronsson, Michael Grätzel, Carine Viornery, Peter Péchy
  • Publication number: 20170205415
    Abstract: The present invention relates to new BARD1 isoforms specific to lung cancer and colorectal cancer, a method for detecting thereof and a method for treating and/or preventing lung cancer and colorectal cancer.
    Type: Application
    Filed: January 27, 2017
    Publication date: July 20, 2017
    Applicants: Universite de Geneve, Hopitaux Universitaires de Geneve
    Inventors: Irmgard IRMINGER-FINGER, Yong-Qiang ZHANG
  • Patent number: 9708279
    Abstract: The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I): as herein described and pharmaceutical compositions thereof. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: July 18, 2017
    Assignees: UNIVERSITÁ DEGLI STUDI DI MILANO—BICOCCA, UNIVERSITÈ DE GENÈVE, UNIVERSITÈ CLAUDE BERNARD LYON 1
    Inventors: Carlo Gambacorti-Passerini, Luca Mologni, Leonardo Scapozza, William Bisson, Peter Goekjian, Joseph D'Attoma
  • Patent number: 9657064
    Abstract: The present invention relates to a short cell penetrating peptide derived from the Epstein-Barr virus basic leucine zipper transcriptional activator (ZEBRA), optionally linked to a cargo molecule. It also relates to a complex comprising the cell penetrating peptide and a cargo molecule, as well as cells loaded with the complex and the use thereof in therapy and diagnosis.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: May 23, 2017
    Assignees: LES HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVE
    Inventors: Madiha Derouazi, Paul Walker, Pierre-Yves Dietrich
  • Patent number: 9599624
    Abstract: The present invention relates to new BARD1 isoforms specific to lung cancer and colorectal cancer, a method for detecting thereof and a method for treating and/or preventing lung cancer and colorectal cancer.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: March 21, 2017
    Assignees: HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVE
    Inventors: Irmgard Irminger-Finger, Yong-Qiang Zhang
  • Patent number: 9556433
    Abstract: Recombinant nucleic acid molecules are provided that form hair pin structures and can be used to down-regulate gene expression. For example, a nucleic acid molecule can comprise a flanking and lower stem loop sequence from a mir-16 gene; an antisense target sequence; a mir-30 loop sequence; a complement of the anti-sense target sequence; and a lower stem loop complementary to the mir-16 sequence. Methods for down regulating gene expression in a cell using such recombinant nucleic acid molecules are also provided.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: January 31, 2017
    Assignees: Université de Genève, University of Pretoria
    Inventors: Karl-Heinz Krause, Renier Myburgh, Patrick Salmon
  • Patent number: 9549985
    Abstract: Described herein are compositions comprising polymers prepared by melt polycondensation of 2-hydroxyalkyl acids. Methods of making and using the compositions are also disclosed.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: January 24, 2017
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Michael Moeller, Lutz Asmus, Robert Gurny